Skip to main content
logo
USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
14.34
-1.13 (-7.30%)
At close: Aug 10, 2026, 4:00 PM EDT
14.48
+0.14 (0.98%)
After-hours: Aug 10, 2026, 7:46 PM EDT

USANA Health Sciences Cash Flow Statement

Millions USD. Fiscal year is Feb - Jan.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
9.1511.4842.0663.7969.35116.51
Depreciation & Amortization
39.2539.722.2320.421.4122.19
Stock-Based Compensation
14.413.8314.5614.613.3314.3
Other Adjustments
-3.60.42-4.85-0.14-0.961.29
Change in Receivables
-5.37-----
Changes in Inventories
-23.17-34.69-2.122.3515.8-14.7
Changes in Accounts Payable
1.775.2-1.27-0.43-2.66-4.57
Changes in Other Operating Activities
-20.68-13.6-9.62-29.92-12.37-13.79
Operating Cash Flow
16.6322.3560.9970.64103.9121.23
Operating Cash Flow Growth
-71.72%-63.36%-13.66%-32.01%-14.29%-24.42%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-13.67-13.82-10.07-14.49-10.4-12.76
Sale of Property, Plant & Equipment
3.953.910.060.020.010.02
Cash Acquisitions
---203.34--6.53-
Other Investing Activities
1.07-0.210.262.54.56-1.44
Investing Cash Flow
-8.85-10.13-213.09-11.98-12.37-14.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Short-Term Debt Issued
21.617.623.691.5411-
Short-Term Debt Repaid
-30.6-26.6-1.47-0.75-11-
Net Short-Term Debt Issued (Repaid)
-9-922.220.790-
Repurchase of Common Stock
-15.21-27.51-9.44-11.6-25.38-177.84
Net Common Stock Issued (Repurchased)
-15.21-27.51-9.44-11.6-25.38-177.84
Other Financing Activities
-5.57-4.1-3.22-3.43-4.71-3.58
Financing Cash Flow
-29.78-40.69.55-14.24-30.09-181.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Foreign Exchange Rate Adjustments
5.295.11-6.19-2.5-13.782.09
Net Cash Flow
-16.71-23.27-148.7441.9347.67-72.28

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
2.968.5350.9256.1593.5108.46
Free Cash Flow Growth
-93.97%-83.26%-9.31%-39.95%-13.79%-25.36%
FCF Margin
0.32%0.92%5.96%6.10%9.36%9.14%
Free Cash Flow Per Share
0.160.462.662.904.845.33
Levered Free Cash Flow
-16.62-15.4463.442.4881.1392.88
Unlevered Free Cash Flow
-8.4-6.8535.6935.8580.4992.57
SEC Filings: 10-K · 10-Q